Ontology highlight
ABSTRACT: Background
The effectiveness of glucose-lowering drugs (GLDs) is unknown among patients with dementia.Objective
To analyze all-cause mortality among users of six GLDs in dementia and dementia-free subjects, respectively.Methods
This was a longitudinal open-cohort registry-based study using data from the Swedish Dementia Registry, Total Population Register, and four supplemental registers providing data on dementia status, drug usage, confounders, and mortality. The cohort comprised 132,402 subjects with diabetes at baseline, of which 11,401 (8.6%) had dementia and 121,001 (91.4%) were dementia-free. Subsequently, comparable dementia - dementia-free pairs were sampled. Then, as-treated and intention-to-treat exposures to metformin, insulin, sulfonylurea, dipeptidyl-p
SUBMITTER: Secnik J
PROVIDER: S-EPMC9028644 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature